Doctors unleash new weapon to fight pediatric neuroblastoma

(University of Michigan Health System) After the first year of receiving the novel treatment combination, more than half of children with relapsed neuroblastoma saw either a complete or partial remission -- a 53 percent response rate compared to the typical 10 to 12 percent response rate.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news